Prof Alan Boobis OBE PhD CBiol FSB FBTS
On this page
Skip the menu of subheadings on this page.Bio
Emeritus Professor of Toxicology in the Faculty of Medicine at Imperial College London. He has been a member of Imperial College London (initially at the Royal Postgraduate Medical School, which merged with the College in 1997) for almost 40 years.
His main research interests lie in mechanistic toxicology, drug metabolism, toxicity pathway analysis and in the application of knowledge in these areas to risk assessment. He has published around 230 original research papers (H-factor 63) and for several years served as an Editor-in-Chief of Food and Chemical Toxicology.
He is a member of a number of national and international advisory committees, including the Committee on the Medical Effects of Air Pollutants, the WHO Study Group on Tobacco Product Regulation (TobReg) and the WHO Chemical Risk Assessment Network Coordinating Group. He is co-chair of the WHO Mode of Action Steering group, JECFA (veterinary residues – co-chair) and JMPR (alternating co-chair). He has been a member and deputy chair of the UK Advisory Committee on Pesticides, a member and deputy chair of the UK Committee on Toxicity (2003-2012), a member of the UK Committee on Carcinogenicity, the EFSA Panel on Contaminants in the Food Chain and a member and deputy chair of the EFSA Panel on Plant Protection Products. He has also served as a member of the HPA Board Sub-Committee for Radiation, Chemical and Environmental Hazards and the Veterinary Residues Committee.
He is chair of the Board of Trustees of the International Life Sciences Institute (ILSI) a member and a past chair of the Board of Trustees of ILSI HESI and vice-president of the Board of Directors of ILSI Europe. He is involved in several HESI, ILSI Research Foundation and ILSI Europe projects. He is a fellow of the Society of Biology and of the British Toxicology Society. He has served as president and is an honorary member of Eurotox and received the Merit Award in 2009. He is a past chair of the British Toxicology Society and received the John Barnes Prize Lectureship in 2013. He was recipient of the Royal Society of Chemistry Toxicology Award in 2013. He received an OBE in 2003 for his work on the risk assessment of pesticides.
Professor Boobis was re-appointed chair of the Committee on Toxicity with effect from 31st March 2024 for 1 year.
Personal Interest
Category of Interest |
Organisation/Body & Nature of Interest |
---|---|
Employee |
Imperial College London, Department of Medicine (full time until June 2017, part-time from Aug 2017) |
Shareholder |
Bank Santander Barclays Bank BG Group BT Group Centrica Iberdrola SA National Grid Lloyds |
Membership |
ILSI & ILSI HESI Board of Trustees ILSI Europe Board of Directors Science Advisory Board of Swiss Centre for Applied Human Toxicology Dept. of Health Committee on the Medical Effects of Air Pollutants |
Non Personal Interest
Category of Interest |
Organisation/Body & Nature of Interest |
---|---|
Grants |
Horizon 2020 EUROMIX Department of Health & Social Care Public Health England |
Membership |
WHO/FAO JMPR WHO/FAO JECFA (vet) WHO TobReg WG10 TC126 (Intense Machine-smoking Regime for Testing Cigarettes) EUROTOX British Pharmacological Society British Toxicology Society Society of Toxicology (USA) Michigan State University MSU Center for Research on Ingredient Safety (CRIS) (External Advisory Board) |